194. RISK OF AGRANULOCYTOSIS AND NEUTROPENIA IN PATIENTS WITH PARKINSON’S DISEASE PSYCHOSIS RECEIVING CLOZAPINE TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSISPublished on 2025-08-184 months ago